The latest update of “Global Dendritic Cell Cancer Vaccine Market” released by Stratagem Market Insights, forecasts further growth in the global supply and demand. The market report builds upon our previous iteration and the new release reinforces the sentiment that the 2021-2028 period is expected to be a promising period for the global Dendritic Cell Cancer Vaccine Market.
Overview of the Dendritic Cell Cancer Vaccine Market:
Dendritic cells and tumor cell cancer vaccines are currently being used and tested in various clinical trials. Dendritic cells that present tumor antigen have demonstrated effectiveness in in vitro studies. When surviving, a protein encoded by the BIRC5 gene, was identified as prominent tumor-associated antigens, the studies to evaluate the ability of dendritic cells to induce Cytotoxic T lymphocytes immune responses against surviving received a major traction.
Market Dynamics:
High prevalence of cancer is expected to propel growth of the global dendritic cell cancer vaccine market over the forecast period. For instance, according to the study, ‘Trends in thyroid cancer incidence in India’, published in May 2018 in the Journal of Clinical Oncology, the incidence rate of thyroid cancer in India in women increased from 2.4 to 3.9 and in men from 0.9 to 1.3, a relative increase of 62% and 48% respectively during 2004/05 to 2013/14.
Investment in R&D is expected to offer lucrative growth opportunities for players in the global dendritic cell cancer vaccine market. For instance, in May 2021, Beroni Group, an Australia-based biopharmaceutical company, signed a MoU with tella, Inc., a Japan-based company focusing on R&D of dendritic cell vaccine therapy, to collaborate in the field of immunotherapy for cancer treatment.
Major players operating in the global dendritic cell cancer vaccine market are focused on R&D to expand their product portfolio. For instance, in November 2021, Alligator Bioscience initiated a Phase Ib clinical trial to assess the safety and efficacy of mitazalimab in combination with MesoPher, an experimental dendritic cell vaccine, in patients with pancreatic cancer.
Key Takeaways:
- High prevalence of cancer is expected to propel growth of the global dendritic cell cancer vaccine market over the forecast period. For instance, according to the Centers of Disease Control and Prevention’s S. Cancer Statistics September 2019, around 94,000 women were diagnosed with gynecologic cancer each year, in the U.S., between 2012 and 2016.
- Major players operating in the global dendritic cell cancer vaccine market are focused on R&D to expand their product portfolio. For instance, in June 2021, AIVITA Biomedical Inc. announced that its personalized cancer vaccine comprised of autologous dendritic cells AV-GBM-1 significantly improved progression-free survival over standard of care in patients with newly diagnosed glioblastoma.
- Major players operating in the global dendritic cell cancer vaccine market include, Medigene, Activarti, Argos Therapeutics, Batavia Bioservices, Bellicum Pharmaceuticals, Creagene, DanDrit Biotech, DCPrime, Sanpower (Dendreon), Elios Therapeutics, Immunicum, Kiromic, Merck, Northwest Biotherapeutics, Glaxo Smith Kline, ImmunoCellular, Tella, Vaxil Bio, and SOTIO
Market Estimation:
The data processed and validated in secondary and primary research is analyzed to compute market estimation statistics. It involves market breakdown, bottom-up, and top-down research. Our research team considers macroeconomic factors to forecast a comprehensive statistical time series. Each data point is validated through the process data triangulation method to derive the final market estimation.
COVID-19 Impact:
The updated report, free extract available, comes with an option to access premium features that covers extensive past, current, and future data. Other valuable updates to the global Dendritic Cell Cancer Vaccine Market report include a reviewed and refined pricing model for manufacturing and launch prices. The report incorporates new content to help give decision-makers key knowledge about the market and offers up-to-date forecasts accounting for the economic situation and impact of COVID-19.
Market Competition Assessment:
The Dendritic Cell Cancer Vaccine Market is observed as the most diversified and competitive market comprising a large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are
- Medigene
- Activarti
- Argos Therapeutics
- Batavia Bioservices
- Bellicum Pharmaceuticals
- Creagene
- DanDrit Biotech
- DCPrime
- Sanpower (Dendreon)
- Elios Therapeutics
- Immunicum
- Kiromic
- Merck
- Northwest Biotherapeutics
- Glaxo Smith Kline
- ImmunoCellular
- Tella
- Vaxil Bio
- SOTIO
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2028. For the purpose of this study, Stratagem Market Insights has segmented the global Dendritic Cell Cancer Vaccine Market report on the basis of Types, Applications, and Regions.
By Product Type, the market is primarily segmented into:
- CreaVax
- Sipuleucel-T (Provenge)
- Others
By Applications, the market is segmented into:
The report covers the following Regions:
- North America
- Latin America
- Europe
- Asia Pacific
- Africa
- Middle East
Primary Research Insights:
The process of primary research starts with the verification and validation of every detail obtained in secondary research. This is done with the help of industry experts and in-house analysts who check the authentication of the data. Stratagem Market Insights also ensures that our research is not restricted by certain boundaries, which is why we consult each individual in the value chain including raw materials suppliers, local vendors, wholesale dealers, distributors, etc. We also make sure that every detail provided in the document will hold a certain value and it will not be trivial information. Moreover, current market trends, growth opportunities, drivers, and restraints are computed in primary research only.
The Report Sheds Light on Various Aspects of the Market, Some of the important ones are:
- What can be the best investment choices for venturing into new product and service lines?
- Which regions might see the demand maturing in certain segments in near future?
- Which government regulations might challenge the status of key regional markets?
- What are some of the value-grab opportunities in various segments?
- What will be the barrier to entry for new players in the market?
Why You Should Buy This Report:
- The report provides an all-inclusive environment of the analysis for the market
- In-depth secondary research and primary interviews
- Impact of various social, political, and economic factors
- Porter’s Five Forces Analysis
- Competitive Landscape
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into a specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Dendritic Cell Cancer Vaccine Market Revenue
1.4 Market Analysis by Type
1.5 Market by Application
1.5.1 Global Dendritic Cell Cancer Vaccine Market Share by Application: 2021 VS 2028
1.6 Coronavirus Disease 2019 (Covid-19) Impact: Dendritic Cell Cancer Vaccine Market
1.6.1 How the Covid-19 is Affecting the Dendritic Cell Cancer Vaccine Market
1.6.1.1 Dendritic Cell Cancer Vaccine Market Business Impact Assessment - Covid-19
1.6.2 Market Trends and Dendritic Cell Cancer Vaccine Market Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Dendritic Cell Cancer Vaccine Market Perspective (2015-2028)
2.2 Dendritic Cell Cancer Vaccine Market Growth Trends by Regions
2.2.1 Dendritic Cell Cancer Vaccine Market Size by Regions: 2015 VS 2021 VS 2028
2.2.2 Dendritic Cell Cancer Vaccine Market Historic Market Share by Regions (2015-2021)
2.2.3 Dendritic Cell Cancer Vaccine Market Forecasted Market Size by Regions (2021-2028)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Dendritic Cell Cancer Vaccine Market Growth Strategy
2.3.6 Primary Interviews with Key Dendritic Cell Cancer Vaccine Market Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Dendritic Cell Cancer Vaccine Market Players by Market Size
3.1.1 Global Top Dendritic Cell Cancer Vaccine Market Players by Revenue (2015-2021)
3.1.2 Global Dendritic Cell Cancer Vaccine Market Revenue Market Share by Players (2015-2021)
3.1.3 Global Dendritic Cell Cancer Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Dendritic Cell Cancer Vaccine Market Concentration Ratio
3.2.1 Global Dendritic Cell Cancer Vaccine Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Dendritic Cell Cancer Vaccine Market Revenue in 2019
3.3 Dendritic Cell Cancer Vaccine Market Key Players Head office and Area Served
3.4 Key Players Dendritic Cell Cancer Vaccine Market Product Solution and Service
3.5 Date of entering into Dendritic Cell Cancer Vaccine Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2028)
4.1 Global Dendritic Cell Cancer Vaccine Market Historic Market Size by Type (2015-2021)
4.2 Global Dendritic Cell Cancer Vaccine Market Forecasted Market Size by Type (2021-2028)
5 Dendritic Cell Cancer Vaccine Market Breakdown Data by Application (2015-2028)
5.1 Global Dendritic Cell Cancer Vaccine Market Size by Application (2015-2021)
5.2 Global Dendritic Cell Cancer Vaccine Market Forecasted Market Size by Application (2021-2028)
6 North America
6.1 North America Dendritic Cell Cancer Vaccine Market Size (2015-2021)
6.2 Dendritic Cell Cancer Vaccine Market Key Players in North America (2019-2021)
6.3 North America Dendritic Cell Cancer Vaccine Market Size by Type (2015-2021)
6.4 North America Dendritic Cell Cancer Vaccine Market Size by Application (2015-2021)
7 Europe
7.1 Europe Dendritic Cell Cancer Vaccine Market Size (2015-2021)
7.2 Dendritic Cell Cancer Vaccine Market Key Players in Europe (2019-2021)
7.3 Europe Dendritic Cell Cancer Vaccine Market Size by Type (2015-2021)
7.4 Europe Dendritic Cell Cancer Vaccine Market Size by Application (2015-2021)
8 China
8.1 China Dendritic Cell Cancer Vaccine Market Size (2015-2021)
8.2 Dendritic Cell Cancer Vaccine Market Key Players in China (2019-2021)
8.3 China Dendritic Cell Cancer Vaccine Market Size by Type (2015-2021)
8.4 China Dendritic Cell Cancer Vaccine Market Size by Application (2015-2021)
9 Japan
9.1 Japan Dendritic Cell Cancer Vaccine Market Size (2015-2021)
9.2 Dendritic Cell Cancer Vaccine Market Key Players in Japan (2019-2021)
9.3 Japan Dendritic Cell Cancer Vaccine Market Size by Type (2015-2021)
9.4 Japan Dendritic Cell Cancer Vaccine Market Size by Application (2015-2021)
10 Southeast Asia
10.1 Southeast Asia Dendritic Cell Cancer Vaccine Market Size (2015-2021)
10.2 Dendritic Cell Cancer Vaccine Market Key Players in Southeast Asia (2019-2021)
10.3 Southeast Asia Dendritic Cell Cancer Vaccine Market Size by Type (2015-2021)
10.4 Southeast Asia Dendritic Cell Cancer Vaccine Market Size by Application (2015-2021)
11 India
11.1 India Dendritic Cell Cancer Vaccine Market Size (2015-2021)
11.2 Dendritic Cell Cancer Vaccine Market Key Players in India (2019-2021)
11.3 India Dendritic Cell Cancer Vaccine Market Size by Type (2015-2021)
11.4 India Dendritic Cell Cancer Vaccine Market Size by Application (2015-2021)
12 Central & South America
12.1 Central & South America Dendritic Cell Cancer Vaccine Market Size (2015-2021)
12.2 Dendritic Cell Cancer Vaccine Market Key Players in Central & South America (2019-2021)
12.3 Central & South America Dendritic Cell Cancer Vaccine Market Size by Type (2015-2021)
12.4 Central & South America Dendritic Cell Cancer Vaccine Market Size by Application (2015-2021)
13 Key Players Profiles
13.1 Company Details
13.2 Business Overview and Its Total Revenue
13.3 Dendritic Cell Cancer Vaccine Market Introduction
13.4 Dendritic Cell Cancer Vaccine Market Business (2015-2021)
13.5 Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Table
Table 1. Dendritic Cell Cancer Vaccine Market Key Market Segments
Table 2. Key Players Covered: Ranking by Dendritic Cell Cancer Vaccine Market Revenue
Table 3. Ranking of Global Top Dendritic Cell Cancer Vaccine Market Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Dendritic Cell Cancer Vaccine Market Size Growth Rate by Type (US$ Million): 2021 VS 2028
Table 5. COVID-19 Impact Global Market
Table 6. Opportunities and Trends for Dendritic Cell Cancer Vaccine Market Players in the COVID-19 Landscape
Table 7. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 8. Key Regions/Countries Measures against Covid-19 Impact
Table 9. Proposal for Dendritic Cell Cancer Vaccine Market Players to Combat Covid-19 Impact
Table 10. Global Dendritic Cell Cancer Vaccine Market Size Growth by Application (US$ Million): 2021 VS 2028
Table 11. Global Dendritic Cell Cancer Vaccine Market Size by Regions (US$ Million): 2021 VS 2028
Table 12. Global Dendritic Cell Cancer Vaccine Market Size by Regions (2015-2021) (US$ Million)
Table 13. Global Dendritic Cell Cancer Vaccine Market Share by Regions (2015-2021)
Table 14. Global Dendritic Cell Cancer Vaccine Market Forecasted Market Size by Regions (2021-2028) (US$ Million)
Table 15. Global Dendritic Cell Cancer Vaccine Market Share by Regions (2021-2028)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Dendritic Cell Cancer Vaccine Market Growth Strategy
Table 20. Main Points Interviewed from Key Dendritic Cell Cancer Vaccine Market Players
Table 21. Global Dendritic Cell Cancer Vaccine Market Revenue by Players (2015-2021) (Million US$)
Table 22. Global Dendritic Cell Cancer Vaccine Market Share by Players (2015-2021)
Table 23. Global Top Dendritic Cell Cancer Vaccine Market Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dendritic Cell Cancer Vaccine Market as of 2019)
Table 24. Global Dendritic Cell Cancer Vaccine Market by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Dendritic Cell Cancer Vaccine Market Product Solution and Service
Table 27. Date of entering into Dendritic Cell Cancer Vaccine Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Dendritic Cell Cancer Vaccine Market Size by Type (2015-2021) (Million US$)
Table 30. Global Dendritic Cell Cancer Vaccine Market Size Share by Type (2015-2021)
Table 31. Global Dendritic Cell Cancer Vaccine Market Revenue Market Share by Type (2021-2028)
Table 31. Global Dendritic Cell Cancer Vaccine Market Size Share by Application (2015-2021)
Table 33. Global Dendritic Cell Cancer Vaccine Market Size by Application (2015-2021) (Million US$)
Table 34. Global Dendritic Cell Cancer Vaccine Market Size Share by Application (2021-2028)
Table 35. North America Key Players Dendritic Cell Cancer Vaccine Market Revenue (2019-2021) (Million US$)
Table 36. North America Key Players Dendritic Cell Cancer Vaccine Market Share (2019-2021)
Table 37. North America Dendritic Cell Cancer Vaccine Market Size by Type (2015-2021) (Million US$)
Table 38. North America Dendritic Cell Cancer Vaccine Market Share by Type (2015-2021)
Table 39. North America Dendritic Cell Cancer Vaccine Market Size by Application (2015-2021) (Million US$)
Table 40. North America Dendritic Cell Cancer Vaccine Market Share by Application (2015-2021)
Table 41. Europe Key Players Dendritic Cell Cancer Vaccine Market Revenue (2019-2021) (Million US$)
Table 42. Europe Key Players Dendritic Cell Cancer Vaccine Market Share (2019-2021)
Table 43. Europe Dendritic Cell Cancer Vaccine Market Size by Type (2015-2021) (Million US$)
Table 44. Europe Dendritic Cell Cancer Vaccine Market Share by Type (2015-2021)
Table 45. Europe Dendritic Cell Cancer Vaccine Market Size by Application (2015-2021) (Million US$)
Table 46. Europe Dendritic Cell Cancer Vaccine Market Share by Application (2015-2021)
Table 47. China Key Players Dendritic Cell Cancer Vaccine Market Revenue (2019-2021) (Million US$)
Table 48. China Key Players Dendritic Cell Cancer Vaccine Market Share (2019-2021)
Table 49. China Dendritic Cell Cancer Vaccine Market Size by Type (2015-2021) (Million US$)
Table 50. China Dendritic Cell Cancer Vaccine Market Share by Type (2015-2021)
Table 51. China Dendritic Cell Cancer Vaccine Market Size by Application (2015-2021) (Million US$)
Table 52. China Dendritic Cell Cancer Vaccine Market Share by Application (2015-2021)
Table 53. Japan Key Players Dendritic Cell Cancer Vaccine Market Revenue (2019-2021) (Million US$)
Table 54. Japan Key Players Dendritic Cell Cancer Vaccine Market Share (2019-2021)
Table 55. Japan Dendritic Cell Cancer Vaccine Market Size by Type (2015-2021) (Million US$)
Table 56. Japan Dendritic Cell Cancer Vaccine Market Share by Type (2015-2021)
Table 57. Japan Dendritic Cell Cancer Vaccine Market Size by Application (2015-2021) (Million US$)
Table 58. Japan Dendritic Cell Cancer Vaccine Market Share by Application (2015-2021)
Table 59. Southeast Asia Key Players Dendritic Cell Cancer Vaccine Market Revenue (2019-2021) (Million US$)
Table 60. Southeast Asia Key Players Dendritic Cell Cancer Vaccine Market Share (2019-2021)
Table 61. Southeast Asia Dendritic Cell Cancer Vaccine Market Size by Type (2015-2021) (Million US$)
Table 62. Southeast Asia Dendritic Cell Cancer Vaccine Market Share by Type (2015-2021)
Table 63. Southeast Asia Dendritic Cell Cancer Vaccine Market Size by Application (2015-2021) (Million US$)
Table 64. Southeast Asia Dendritic Cell Cancer Vaccine Market Share by Application (2015-2021)
Table 65. India Key Players Dendritic Cell Cancer Vaccine Market Revenue (2019-2021) (Million US$)
Table 66. India Key Players Dendritic Cell Cancer Vaccine Market Share (2019-2021)
Table 67. India Dendritic Cell Cancer Vaccine Market Size by Type (2015-2021) (Million US$)
Table 68. India Dendritic Cell Cancer Vaccine Market Share by Type (2015-2021)
Table 69. India Dendritic Cell Cancer Vaccine Market Size by Application (2015-2021) (Million US$)
Table 70. India Dendritic Cell Cancer Vaccine Market Share by Application (2015-2021)
Table 71. Central & South America Key Players Dendritic Cell Cancer Vaccine Market Revenue (2019-2021) (Million US$)
Table 72. Central & South America Key Players Dendritic Cell Cancer Vaccine Market Share (2019-2021)
Table 73. Central & South America Dendritic Cell Cancer Vaccine Market Size by Type (2015-2021) (Million US$)
Table 74. Central & South America Dendritic Cell Cancer Vaccine Market Share by Type (2015-2021)
Table 75. Central & South America Dendritic Cell Cancer Vaccine Market Size by Application (2015-2021) (Million US$)
Table 76. Central & South America Dendritic Cell Cancer Vaccine Market Share by Application (2015-2021)
Table 77. Company Details
Table 78. Business Overview
Table 79. Product details
Table 80. Revenue in Dendritic Cell Cancer Vaccine Market Business (2015-2021) (Million US$)
Table 81. Recent Development
List of Figures
Figure 1. Global Dendritic Cell Cancer Vaccine Market Share by Type: 2021 VS 2028
Figure 2. Global Dendritic Cell Cancer Vaccine Market Share by Application: 2021 VS 2028
Figure 3. Emergency Care Case Studies
Figure 4. Outpatient Facilities Case Studies
Figure 5. Hospitals Case Studies
Figure 6. Home Healthcare Facilities Case Studies
Figure 7. Dendritic Cell Cancer Vaccine Market Report Years Considered
Figure 8. Global Dendritic Cell Cancer Vaccine Market Size YoY Growth 2015-2028 (US$ Million)
Figure 9. Global Dendritic Cell Cancer Vaccine Market Share by Regions: 2021 VS 2028
Figure 10. Global Dendritic Cell Cancer Vaccine Market Share by Regions (2021-2028)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Dendritic Cell Cancer Vaccine Market Share by Players in 2019
Figure 13. Global Top Dendritic Cell Cancer Vaccine Market Players by Company Type (Tier 1, Tier 2, and Tier 3) (based on the Revenue in Dendritic Cell Cancer Vaccine Market as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Dendritic Cell Cancer Vaccine Market Revenue in 2019
Figure 15. North America Dendritic Cell Cancer Vaccine Market Size YoY Growth (2015-2021) (Million US$)
Figure 16. Europe Dendritic Cell Cancer Vaccine Market Size YoY Growth (2015-2021) (Million US$)
Figure 17. China Dendritic Cell Cancer Vaccine Market Size YoY Growth (2015-2021) (Million US$)
Figure 18. Japan Dendritic Cell Cancer Vaccine Market Size YoY Growth (2015-2021) (Million US$)
Figure 19. Southeast Asia Dendritic Cell Cancer Vaccine Market Size YoY Growth (2015-2021) (Million US$)
Figure 20. India Dendritic Cell Cancer Vaccine Market Size YoY Growth (2015-2021) (Million US$)
Figure 21. Central & South America Dendritic Cell Cancer Vaccine Market Size YoY Growth (2015-2021) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
Request Discount 
Inquire Before Buy
